We are live on ! Find out more
BLUE

bluebird bio
BLUE

Delisted

BLUE was delisted on the 30th of May, 2025.

Back to rankings

174 hedge funds and large institutions have $303M invested in bluebird bio in 2022 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 54 increasing their positions, 45 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 45

13% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 32

1% more funds holding

Funds holding: 172 → 174 (+2)

0.19% more ownership

Funds ownership: 4.15% → 4.34% (+0.19%)

48% less capital invested

Capital invested by funds: $581M → $303M (-$279M)

54% less call options, than puts

Call options by funds: $961K | Put options by funds: $2.09M

Holders
174
Holders Change
+2
Holders Change %
+1.16%
% of All Funds
2.74%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
36
Increased
54
Reduced
45
Closed
32
Calls
$961K
Puts
$2.09M
Net Calls
-$1.13M
Net Calls Change
+$601K

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$36.5M
2
TCM
Tang Capital Management
California
+$10.2M
3
Morgan Stanley
Morgan Stanley
New York
+$7.16M
4
Renaissance Technologies
Renaissance Technologies
New York
+$6.2M
5
Voloridge Investment Management
Voloridge Investment Management
Florida
+$4.49M

Top Sellers

Rank Fund Capital Flow
1
First Trust Advisors
First Trust Advisors
Illinois
-$52M
2
AC
Armistice Capital
New York
-$23.5M
3
SC
Sessa Capital
New York
-$9.11M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$8.62M
5
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
-$5.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
176
Corton Capital
Ontario, Canada
– -$491K -2,460 Closed
PM
177
Parametrica Management
Hong Kong
– -$401K -2,007 Closed
AFM
178
Anson Funds Management
Texas
– -$350K -1,752 Closed
CAM
179
Cresset Asset Management
Illinois
– -$255K -1,276 Closed
BAM
180
Blueshift Asset Management
New Jersey
– -$253K -1,264 Closed
FT
181
Fiduciary Trust
Massachusetts
– -$223K -1,114 Closed
DU
182
Delphia (USA)
Ontario, Canada
– -$191K -955 Closed
XT
183
XTX Topco
Cayman Islands
– -$167K -836 Closed
EAM
184
Erste Asset Management
Austria
– -$156K -750 Closed
SCA
185
Spearhead Capital Advisors
Florida
– -$146K -730 Closed
SO
186
STRS Ohio
Ohio
– -$76K -385 Closed
Canada Pension Plan Investment Board
187
Canada Pension Plan Investment Board
Ontario, Canada
– -$28K -138 Closed
GWM
188
Geneos Wealth Management
Colorado
– -$10K -54 Closed
EVM
189
Eaton Vance Management
Massachusetts
– -$5K -25 Closed
DFCM
190
Dark Forest Capital Management
Puerto Rico
– -$4K -22 Closed
TCOV
191
Trust Company of Vermont
Vermont
– -$6K -13 Closed
CLOS
192
Compagnie Lombard Odier SCmA
Switzerland
– -$2K -12 Closed
TC
193
Truvestments Capital
Florida
– -$1K -7 Closed
PA
194
Parallel Advisors
California
– -$792 -6 -75%
HR
195
Howe & Rusling
New York
– -$132 -1 -50%
CAL
196
Capital Advisors Ltd
Ohio
– +$264 +2 New
LAS
197
Lloyd Advisory Services
Georgia
– +$396 +3 New
4 5 6 7
8

BLUE Hedge Fund Activity: Q1 2022 in Review

174 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in bluebird bio (BLUE) for Q1 2022, worth a combined $303M — down 48% from $581M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new BLUE positions and 32 closed out — a net gain of 4 holders — while 54 added to existing stakes and 45 trimmed.

The largest buyer was State Street, adding an estimated $36.5M. The largest seller was First Trust Advisors, exiting entirely with an estimated $52M sold.

  • 174 institutional investors held bluebird bio (BLUE) as of Q1 2022, up from 172 in Q4 2021.
  • Funds reported $303M of bluebird bio stock for Q1 2022, down 48% quarter-over-quarter.
  • 36 funds opened new bluebird bio positions in Q1 2022 and 32 closed out, a net change of +4 holders.
  • The largest bluebird bio buyer in Q1 2022 was State Street, an estimated $36.5M added.
  • The largest bluebird bio seller in Q1 2022 was First Trust Advisors, an estimated $52M sold.

Based on aggregated 13F filings for Q1 2022.